BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol. 2008;23:1716-1721. [PMID: 18761557 DOI: 10.1111/j.1440-1746.2008.05482.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhu M, Dai J, Wang C, Wang Y, Qin N, Ma H, Song C, Zhai X, Yang Y, Liu J, Liu L, Li S, Liu J, Yang H, Zhu F, Shi Y, Shen H, Jin G, Zhou W, Hu Z. Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese. Hum Mol Genet 2016;25:1225-32. [DOI: 10.1093/hmg/ddw003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
2 Vukobrat-Bijedic Z, Mehmedovic A, Redzepovic A, Gogov B. Use of serum levels of proinflammatory cytokine IL-1alpha in chronic hepatitis B. Med Arch 2014;68:94-7. [PMID: 24937930 DOI: 10.5455/medarh.2014.68.94-97] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP, Tian Y, Li RC, Li Z, Zhu X. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One. 2011;6:e17608. [PMID: 21408128 DOI: 10.1371/journal.pone.0017608] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
4 Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, Eslamifar A, Jourabchi A, Farazi AA, Ramezani A. No correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome. Hepat Mon 2013;13:e8803. [PMID: 23922563 DOI: 10.5812/hepatmon.8803] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
5 Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell 2012;3:364-71. [PMID: 22610888 DOI: 10.1007/s13238-012-2036-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 11.0] [Reference Citation Analysis]
6 Li N, Gao YF, Zhang TC, Chen P, Li X, Su F. Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol 2012; 4(3): 105-109 [PMID: 22489263 DOI: 10.4254/wjh.v4.i3.105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
7 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
8 Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, Liu Y, Gong H, Zhu Y, Liu F, Wu J. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J. 2011;25:4511-4521. [PMID: 21903935 DOI: 10.1096/fj.11-187781] [Cited by in Crossref: 119] [Cited by in F6Publishing: 122] [Article Influence: 10.8] [Reference Citation Analysis]
9 Zhang W, Lv F, Gao YF, Zou GZ, Pan FM, Li X. Association between BTLA polymorphisms and genetic susceptibility to chronic HBV infection. Shijie Huaren Xiaohua Zazhi 2015; 23(15): 2373-2381 [DOI: 10.11569/wcjd.v23.i15.2373] [Reference Citation Analysis]
10 Miao F, Sun H, Pan N, Xu J, Qiu J, Shen Y, Xie W, Zhang J. Association of human leukocyte antigen class I polymorphism with spontaneous clearance of hepatitis B surface antigen in Qidong Han population. Clin Dev Immunol 2013;2013:145725. [PMID: 24324503 DOI: 10.1155/2013/145725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kapoor R, Kottilil S. Strategies to eliminate HBV infection. Future Virol 2014;9:565-85. [PMID: 25309617 DOI: 10.2217/fvl.14.36] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
12 Albayrak A, Ertek M, Tasyaran MA, Pirim I. Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet. 2011;49:258-269. [PMID: 21188498 DOI: 10.1007/s10528-010-9404-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
13 Julg B, Moodley ES, Qi Y, Ramduth D, Reddy S, Mncube Z, Gao X, Goulder PJ, Detels R, Ndung'u T, Walker BD, Carrington M. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J Infect Dis 2011;203:803-9. [PMID: 21257739 DOI: 10.1093/infdis/jiq122] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
14 Ma J, Guo X, Wu X, Li J, Zhu X, Li Z, Li J, Pan L, Li T, Li H, Liu Y. Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population. J Med Virol 2010;82:1501-7. [PMID: 20648603 DOI: 10.1002/jmv.21855] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
15 Ning G, Zhen LM, Xu WX, Li XJ, Wu LN, Liu Y, Xie C, Peng L. Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients. J Viral Hepat 2020;27:1071-81. [PMID: 32384193 DOI: 10.1111/jvh.13319] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ, Li Z, Yang J. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 2012;8:e1002791. [PMID: 22807686 DOI: 10.1371/journal.pgen.1002791] [Cited by in Crossref: 128] [Cited by in F6Publishing: 130] [Article Influence: 12.8] [Reference Citation Analysis]
17 Arango M, Perricone C, Kivity S, Cipriano E, Ceccarelli F, Valesini G, Shoenfeld Y. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol Res 2017;65:82-98. [DOI: 10.1007/s12026-016-8817-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
18 Lv F, Gao YF, Zhang ZH, Zhang TC, Pan FM, Cui MF, Xia SL, Li X, Yin HF. Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients. World J Hepatol 2011; 3(3): 72-78 [PMID: 21487538 DOI: 10.4254/wjh.v3.i3.72] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
19 Constantinescu I, Boșcaiu V, Cianga P, Dinu AA, Gai E, Melinte M, Moise A. The frequency of HLA alleles in the Romanian population. Immunogenetics 2016;68:167-78. [PMID: 26711124 DOI: 10.1007/s00251-015-0891-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Li HY, Wu JZ, Wu JL, Pang Y, Jiang CY, Qin L, Wei KL. Association between HLA-DRB1*11/14 alleles and HBV-related liver diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(28): 2672-2677 [DOI: 10.11569/wcjd.v20.i28.2672] [Reference Citation Analysis]
21 Ren L, Deng Y, Wang HJ, Ren B, Niu XY, Fan HN. Association of the HLA-DRB1 gene with clinical outcome of Tibetan patients with hepatitis B in Qinghai. Shijie Huaren Xiaohua Zazhi 2011; 19(18): 1899-1903 [DOI: 10.11569/wcjd.v19.i18.1899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Zeng Z. Human genes involved in hepatitis B virus infection. World J Gastroenterol 2014; 20(24): 7696-7706 [PMID: 24976707 DOI: 10.3748/wjg.v20.i24.7696] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
23 Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 2010;398:771-7. [PMID: 20633528 DOI: 10.1016/j.bbrc.2010.07.021] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
24 Li X, Liu W, Wang H, Jin X, Fang S, Shi Y, Liu Z, Zhang S, Yang S. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China. Virus Res. 2012;163:328-333. [PMID: 22056847 DOI: 10.1016/j.virusres.2011.10.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
25 Li F, Li X, Zou GZ, Gao YF, Ye J. Association between TLR7 copy number variations and hepatitis B virus infection outcome in Chinese. World J Gastroenterol 2017; 23(9): 1602-1607 [PMID: 28321161 DOI: 10.3748/wjg.v23.i9.1602] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis S, Severson RK, Bernstein L, Hartge P, Carrington M. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 2010;115:4820-3. [PMID: 20385791 DOI: 10.1182/blood-2010-01-266775] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
27 Jiang H, Cao F, Cao H, Rao Q, Yang Y. Associations of human leukocyte antigen and interleukin-18 gene polymorphisms with viral load in patients with hepatitis B infection. Medicine (Baltimore) 2018;97:e11249. [PMID: 30045250 DOI: 10.1097/MD.0000000000011249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhao XM, Gao YF, Zhou Q, Pan FM, Li X. Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection. World J Gastroenterol 2013; 19(40): 6888-6893 [PMID: 24187466 DOI: 10.3748/wjg.v19.i40.6888] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
29 Huang M, Zhang W, Guo J, Wei X, Phiwpan K, Zhang J, Zhou X. Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. Sci Rep 2016;6:33612. [PMID: 27634283 DOI: 10.1038/srep33612] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
30 Zhang L, Zhou X, Dai Y, Lv C, Wu J, Wu Q, Li T, Wang Y, Xia P, Pei H, Huang B. Establishment of interleukin-18 time-resolved fluorescence immunoassay and its preliminary application in liver disease. J Clin Lab Anal 2021;35:e23758. [PMID: 33720453 DOI: 10.1002/jcla.23758] [Reference Citation Analysis]
31 Bettencourt A, Carvalho C, Leal B, Brás S, Lopes D, Martins da Silva A, Santos E, Torres T, Almeida I, Farinha F, Barbosa P, Marinho A, Selores M, Correia J, Vasconcelos C, Costa PP, da Silva BM. The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases. J Immunol Res 2015;2015:948723. [PMID: 26605347 DOI: 10.1155/2015/948723] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
32 Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012;12:320-325. [PMID: 22783343 DOI: 10.5812/hepatmon.6094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
33 Zhao N, Wang XL, Gu QH, Huang F, Zheng W, Li ZW. Tripartite Motif-Containing 22 Gene -364T/C Polymorphism Associated With Hepatitis B Virus Infection in Chinese Han Population. Hepat Mon 2014;14:e12110. [PMID: 24596578 DOI: 10.5812/hepatmon.12110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]